EmailAIDS 2008: Clinical Management
- AIDS 2008 Conference Highlights: An Interview With David Malebranche, M.D. (Posted Sept. 10, 2008)
From TheBodyPRO.comRead or listen (19 min.): - Reevaluating Prospects for HIV Eradication (Posted Aug. 25, 2008)
Do current antiretrovirals completely stop replication? According to Robert Siliciano, M.D., Ph.D., the answer is yes.
From TheBodyPRO.comRead or listen (5 min.): - More Patients With High Viral Loads Experience Virologic Failure When Starting Therapy With an Abacavir-Based Regimen Than a Tenofovir-Based Regimen (Posted Aug. 20, 2008)
From TheBodyPRO.comRead or listen (9 min.): - Fact Sheet: New Research From AIDS 2008 (Posted Aug. 19, 2008)
From International AIDS Society - Antiretroviral Strategy Update: Highlights From the XVII International AIDS Conference (Posted Aug. 13, 2008)
From TheBodyPRO.comRead or listen (47 min.): - Men More Likely to Drop out of Clinic Care Than Women in Western Kenya (Posted Aug. 8, 2008)
From aidsmap.com - How Does Abacavir/3TC Compare to Tenofovir/FTC? ACTG5202 and GSK Studies Disagree (Posted Aug. 8, 2008)
From aidsmap.com - Two NNRTIs in Development, RDEA806 and IDX899, Look Promising in Early Clinical Trials (Posted Aug. 8, 2008)
From aidsmap.com - TMC278 Nanosuspension Found Long-Acting, Well-Tolerated in First Trial in HIV-Uninfected Subjects (Posted 5, 2008)
The first trial of an experimental formulation of TMC278 (rilpivirine) yields promising results in HIV-uninfected patients.
From TheBodyPRO.comRead or listen (5 min.): - Switching Protease Inhibitors Does Not Compromise Efficacy, Safety, Study Suggests (Posted Aug. 5, 2008)
Ben Young, M.D., discusses the results of his 24-week study, which found that patients switching from a stable PI-based regimen to a fosamprenavir-based regimen maintained similar virologic efficacy and experienced similar rates of adverse events as patients who did not switch.
From TheBodyPRO.comRead or listen (6 min.): - Earlier Treatment of HIV Could Help HIV-Positive People Avoid Long-Term Complications, Recommendations Say (Posted Aug. 5, 2008)
A panel of the International AIDS Society-USA has issued new recommendations for when physicians should initiate HAART.
From the Henry J. Kaiser Family Foundation - Session on Newer Antiretroviral Agents (Posted Aug. 5, 2008)
From the Henry J. Kaiser Family FoundationRead or listen (77 min.): - Earlier ART Benefits HIV/TB Coinfected Patients in Iran; Argentinian Study Yields Uncertain Results (Posted Aug. 4, 2008)
From aidsmap.com
TheBodyPRO.com: About TheBodyPRO.com | Contact TheBodyPRO.com | Content Policy | Advertise With Us
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
TheBodyPRO.com is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
